Rezvilutamide With Radical Prostatectomy and Metastasis-Directed Therapy in Oligometastatic Prostate Cancer | MicrobiomeTrials← Back to trialsNCT07490210
Rezvilutamide With Radical Prostatectomy and Metastasis-Directed Therapy in Oligometastatic Prostate Cancer
RecruitingPHASE2INTERVENTIONAL
Trial Details
Start: 2026-05-01Est. Completion: 2032-05-31
Enrollment target: 300 participants Locations- Fudan University Shanghai Cancer Center, Shanghai, Shanghai Municipality, China
Other microbiome trials you might be interested in
Prostate Cancer
This study aimed to evaluate the diagnostic performance of 18F-DCFPyL (PyL) PET/CT in subjects presenting not previously…
Montreal, CanadaCompleted Nov 1, 2025
Oligometastatic Prostate Cancer (OMPC)
The purpose of this study is to evaluate the efficacy and safety of lutetium (177Lu) vipivotide tetraxetan (AAA617) in p…
Fayetteville, United StatesEst. completion Apr 25, 2028
Metastatic Prostate AdenocarcinomaOligometastatic Prostate CarcinomaProstate AdenocarcinomaRecurrent Prostate CarcinomaStage IVB Prostate Cancer AJCC v8
This phase II trial studies the side effects of radiation therapy \[hypofractionated proton beam radiation therapy (PBRT…
Rochester, United StatesEst. completion Nov 22, 2025